An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
- PMID: 27877219
- PMCID: PMC5118667
- DOI: 10.7150/jca.15323
An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
Abstract
The pancreatic carcinoma is a leading cause of death in cancer carriers worldwide. The early diagnostic is difficult due to late stage during diagnosis, lack of characteristic symptoms and also multifactor basis. In cancer development take part both, environmental and genetic factors, alone or in conjunction with each other. The nonspecific biomarkers of cancers are a reason for the search for more accurate factors which allow for fast and personalized diagnostics. Some of cancers have identified molecular (metabolic, biochemical or genetic) markers but in most cases the only clue is patient`s interview and abnormal levels of organ functions markers. Possible genetic basis of cancer suggests to widen studies on connection between environmental factors with both, nuclear and mitochondrial, genes changes.
Keywords: pancreatic carcinoma; polymorphism..
Conflict of interest statement
The authors have declared that no competing interest exists.
References
-
- Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363:1049–1057. - PubMed
-
- Vitone LJ, Greenhalf W, McFaul C.D. et al. The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol. 2006;20:253–283. - PubMed
-
- Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–1617. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
